FDA approval
Scope
Date
~
-
Bio & Pharma
Vaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer
South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...
Apr 13, 2023 (Gmt+09:00)
-
Corporate investment
S.Korean corporate investment in Vietnam plunges 70% in first quarter
South Korean corporate investment in Vietnam, which has led the economic development of the Southeast Asian nation, has plunged this year due to fac...
Apr 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Verismo's CAR-T therapy designated fast-track status by FDA
Verismo Therapeutics, a US affiliate of South Korean pharmaceutical firm HLB Co., has received fast-track designation from the US Food and Drug Admi...
Apr 07, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Foreigners can enter S.Korean casino without physical passport
Visitors to South Korea will be able to enjoy tax-free shopping and casino experiences with ease, thanks to the mobile passport identity verificatio...
Apr 04, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha's takeover of DSME likely to get conditional approval
South Korea's Fair Trade Commission (FTC) on Monday said it is discussing corrective measures with Hanwha Group over fears that the conglomerate's a...
Apr 04, 2023 (Gmt+09:00)
-
Retail
WRC-approved longest-distance golf ball ATTOMAX on sale in Korea
ATTOMAX golf balls approved by the World Record Committee (WRC) as the longest-flying golf balls in the world finally hit the South Korean market on...
Mar 31, 2023 (Gmt+09:00)
-
Korean games
Will S.Korean games benefit from China’s deregulation?
China is loosening its grip on foreign online games with approvals on 27 titles, raising hopes that South Korean publishers will expand their presen...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's FutureChem gets approval for phase 3 clinical trials in China
South Korean radiopharmaceutical development company FutureChem Co. announced on Thursday that China's National Medical Products Administration (NMP...
Mar 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)
-
Robotics
Korean 3D tech firm Koh Young looks to US medical robot market
Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, is slated to enter the US me...
Mar 15, 2023 (Gmt+09:00)
-
Robotics
Curexo unveils artificial joint surgery robot TMAX at AAOS 2023
Curexo, a South Korean medical robot company, said on Tuesday that it had unveiled its artificial joint surgery robot "TMAX" at AAOS 2023, the world...
Mar 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile
South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's licensed flu vaccine gets approval in Taiwan
South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...
Mar 13, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Business & Politics
Korea clears environmental hurdle for new Jeju airport
South Korea’s environment ministry conditionally approved the construction of a new airport on Jeju Island with a 6.7 trillion won ($5.2 billi...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Energy
KHNP gets EUR certification for nuclear plant model in Europe
Korea Hydro & Nuclear Power (KHNP) on Thursday said the standard design of its APR1000, a nuclear power plant that it exports to Europe, has obt...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong’s Nabota expands into Germany, Austria
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday it had launched its botulinum toxin product Nabota in Germany and Austria through i...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Huons gets approval to supply anesthetics to Canada
Huons Co., a South Korean pharmaceutical company, has announced plans to expand its presence in the North American market by offering two anesthetic...
Feb 28, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Iljin Materials to change its name to Lotte Energy Materials
Lotte Chemical Corp., a South Korean petrochemical giant, will rename Iljin Materials Co., the country’s second-largest copper foil maker, as ...
Feb 28, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
BC Card shows one-stop payment int'l network at MWC 2023
BC Card, the only credit card company from South Korea taking part in this year's Mobile World Congress (MWC) in Barcelona, Spain, is displaying at ...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Jetema applies to test its botulinum toxin in US from July
South Korea's bio-esthetic pharmaceutical company Jetema Co. will hold clinical trials in the US to advance to the American market, the world's bigg...
Feb 27, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Turkey approves Hanwha Group's acquisition of DSME
The Turkish competition authority has approved Hanwha Group’s acquisition of Daewoo Shipbuilding & Marine Engineering Co. (DSME), the firs...
Feb 22, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...
Feb 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Hwajin Medical gets FDA sales approval for syringes
HLB Therapeutics Co. announced Thursday that Sofjec, a syringe produced by its subsidiary Hwajin Medical, has been approved for sale by the US Food ...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
EOFlow's insulin injection pump starts to be sold in UAE
South Korea's medical device maker EOFlow Co. started selling the wearable insulin pump EOPatch in the United Arab Emirates.The company said on Tues...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)